The novel class of GLP-1 agonist medication and GIP dual medications, like tirzepatide, semaglutide, and the recently introduced retatrutide, represent groundbreaking advances in diabetes management . https://retatrutide486937.designi1.com/64477624/semaglutide-a-comparative-review